Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Characterization of Fetal Lung With Quantitative Ultrasound

NCT: NCT06722365 · RECRUITING

NCT IDNCT06722365
StatusRECRUITING
Start Date2024-12-17
Completion2027-06
SponsorUniversity of Wisconsin, Madison (OTHER)
First posted
Last updated

Brief Summary

The purpose of the study is to show if it's possible to use a special kind of ultrasound called backscatter quantitative ultrasound (bQUS) to check on a baby's lungs when the mother is 36 weeks pregnant. 16 participants will be on study for a single 30 minute ultrasound between 32 and 36 weeks of pregnancy.

Frequently Asked Questions

What is Characterization of Fetal Lung With Quantitative Ultrasound?

Characterization of Fetal Lung With Quantitative Ultrasound is a clinical trial registered under NCT06722365. Current status: RECRUITING.

What is the status of NCT06722365?

The current status of NCT06722365 (Characterization of Fetal Lung With Quantitative Ultrasound) is: RECRUITING.

When did Characterization of Fetal Lung With Quantitative Ultrasound start?

Characterization of Fetal Lung With Quantitative Ultrasound started on 2024-12-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.